U.S. markets close in 1 hour 43 minutes
  • S&P 500

    3,839.74
    -30.55 (-0.79%)
     
  • Dow 30

    31,427.17
    +35.65 (+0.11%)
     
  • Nasdaq

    13,057.77
    -301.02 (-2.25%)
     
  • Russell 2000

    2,230.50
    -1.01 (-0.05%)
     
  • Crude Oil

    61.41
    +1.66 (+2.78%)
     
  • Gold

    1,715.70
    -17.90 (-1.03%)
     
  • Silver

    26.31
    -0.57 (-2.14%)
     
  • EUR/USD

    1.2071
    -0.0016 (-0.13%)
     
  • 10-Yr Bond

    1.4670
    +0.0520 (+3.67%)
     
  • GBP/USD

    1.3962
    +0.0005 (+0.04%)
     
  • USD/JPY

    106.9900
    +0.2800 (+0.26%)
     
  • BTC-USD

    50,831.34
    +2,906.74 (+6.07%)
     
  • CMC Crypto 200

    1,017.48
    +29.38 (+2.97%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Avantor: Q4 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Avantor (NYSE:AVTR) rose in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share were up 52.63% over the past year to $0.29, which beat the estimate of $0.26.

Revenue of $1,791,000,000 up by 17.52% year over year, which beat the estimate of $1,690,000,000.

Outlook

Earnings guidance hasn't been issued by the company for now.

Avantor hasn't issued any revenue guidance for the time being.

Details Of The Call

Date: Feb 03, 2021

View more earnings on AVTR

Time: 05:00 PM

ET Webcast URL: https://event.on24.com/wcc/r/2948500/8B4362B553C7B00357AF20EE10DA6765

Technicals

52-week high: $30.99

Company's 52-week low was at $6.66

Price action over last quarter: Up 27.34%

Company Overview

Avantor Inc is involved in providing products and services to biopharma, healthcare, education and government, and advanced technologies and applied materials industries. The company's offerings include materials and consumables, equipment and instrumentation and services and specialty procurement. Its brand profile consists of NuSil, RANKEM, POCH, BeneSphera, and Macron Fine Chemicals among others. The firm operates in three geographical segments namely Americas, Europe, and AMEA. It generates a majority of its revenue from the Americas.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.